Lataa...
Update on immune checkpoint inhibitors in gynecological cancers
In recent years, progress in our understanding of immune-modulatory signaling pathways in immune cells and the tumor microenvironment (TME) has led to rejuvenated interest in cancer immunotherapy. In particular, immunotherapy targeting the immune checkpoint receptors such as cytotoxic T-lymphocyte-a...
Tallennettuna:
| Julkaisussa: | J Gynecol Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323287/ https://ncbi.nlm.nih.gov/pubmed/28028993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2017.28.e20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|